(Press-News.org) BOSTON—Researchers have long known that cancerous tumors grow collections of abnormal blood cells, the fuel that feeds this disease and keeps it growing. Now, new evidence in an animal model suggests that blood vessels in the fat tissue of obese individuals could provide the same purpose—and could provide the key to a new way for people to lose weight. When researchers Jian-Wei Gu, Kristina L. Makey, Edmund Chinchar, Carissa Howie, and Lucio Miele, all from the University of Mississippi Medical Center, gave obese mice a cancer drug that works by inhibiting the growth of blood vessels, these mice lost about 70 percent of their fat mass.
The team will discuss an abstract of their study entitled, "Angiogenesis Inhibitor, Sunitinib, Significantly Reduces Adipose Tissue Mass in High Fat Diet-Induced Postmenopausal Obese Mice," at the Experimental Biology 2013 meeting, being held April 20-24, 2013 at the Boston Convention and Exhibition Center, Boston, Mass. The poster presentation is sponsored by the American Physiological Society (APS), a co-sponsor of the event. As the findings are being presented at a scientific conference, they should be considered preliminary, as they have not undergone the peer review process that is conducted prior to the data being published in a scientific journal.
Treating Fat and Cancer the Same
Dr. Gu, who led the research team, notes that there are only three drugs currently approved in the United States to treat obesity. Unfortunately, he says, these few drugs are only minimally effective and come with a host of undesirable side effects.
"Right now," he says, "we don't have good drugs that lead to very significant weight loss, and none that don't cause other problems."
More than a decade ago, Judah Folkman of Harvard Medical School, whose primary research focus was the growth of blood vessels in cancerous tumors, discovered that fat tissue in mice can be regulated by angiogenesis inhibitors—drugs that restrain the growth of blood vessels. However, Gu explains, Folkman never pursued this line of research further before his death in 2008.
Building upon Folkman's single paper published on this topic in 2002, Gu, who studies the role of fat tissue in cancer, decided to test whether a drug already developed to inhibit blood vessels for cancer treatment might also reduce fat.
He and his colleagues administered the drug, known as Sunitinib and approved to treat kidney and gastrointestinal tumors, to a mouse model of postmenopausal obesity. These animals, which had their ovaries removed at a young age to put them in premature menopause and fed four weeks of a high fat diet to promote obesity, received Sunitinib daily for two weeks either orally or through abdominal injections. These animals were compared to those of the same model who didn't receive the drug.
Shrinking Blood Vessels, and Fat
After this treatment, researchers found that the mice who received Sunitinib lost significant amounts of weight, with an average loss of 70 percent fat mass. However, notes Gu, their lean mass remained unaffected. Both mice who received the drug orally and those who received abdominal injections lost similar amounts of fat.
In addition to fat loss, Sunitinib also seemed to curb the animals' appetites, with those receiving the drug eating less food once treatment was complete—possibly a side effect of losing the fat and the hormones it sends to the brain to stimulate food intake, Gu explains.
Gu emphasizes that more research is necessary before this drug can be tested for human weight loss. Because many angiogenesis proteins exist for various purposes throughout the body, Sunitinib may cause off-target effects that weren't immediately evident in the mouse models, he notes. Additionally, he and his colleagues plan to test whether this drug is also effective with other types of animal models for obesity.
However, according to the researcher, the findings suggest that Sunitinib holds promise for reducing fat mass. "This could be a very good strategy for treating obesity, at least in the short-term," he says.
###
About Experimental Biology 2013
Six scientific societies will hold their joint scientific sessions and annual meetings, known as Experimental Biology, from April 20-24, 2013, in Boston. This meeting brings together the leading researchers from a broad array of life science disciplines. The societies include the American Association of Anatomists (AAA), American Physiological Society (APS), American Society for Biochemistry and Molecular Biology (ASBMB), American Society for Investigative Pathology (ASIP), American Society for Nutrition (ASN), and American Society for Pharmacology and Experimental Therapeutics (ASPET). Additional information about the meeting is online at http://bit.ly/ymb7av.
About the American Physiological Society (APS)
The American Physiological Society (APS) is a nonprofit organization devoted to fostering education, scientific research, and dissemination of information in the physiological sciences. The Society was founded in 1887 and today represents more than 11,000 members and publishes
14 peer-reviewed journals.
END
BOSTON — Since 1997, a shrubby perennial found only in East Texas has been on a waiting list to be officially declared by the U.S. Fish and Wildlife Service as threatened under the Endangered Species Act. A ruling on the fate of the Neches River rose-mallow is expected by 2016 under a settlement agreement between the feds and a conservation group. If the plant is listed as threatened, it will become eligible for government-funded restoration. But the future of the white-petaled, ruby-throated hibiscus may hinge on its past: The jury is still out on whether the showy plant ...
BOSTON—Parkinson's disease (PD) is a progressive degenerative disease affecting a person's ability to coordinate and control their muscle movement. What starts out as a tremor in a finger will eventually lead to difficulty in writing and speaking, and ultimately the inability to walk without assistance. Since the 1950s research has shown that people with Parkinson's have decreased levels of the chemical dopamine in their brains, which is involved in sending messages to the part of the brain that controls coordination and movement. Subsequent research has found that dopamine-generating ...
Boston, MA—The microbiome is your body's set of microbial communities; microbial cells outnumber human cells roughly ten to one. Through studying the microbiome, scientists are learning more the relationship between these microbes and human health and disease. In looking at the effect of diet on the composition of the gut microbiome, Dr. Nanette Steinle of the University of Maryland's School of Medicine and Dr. Emmanuel Mongodin of the University of Maryland Institute of Genome Sciences wanted to determine if the Mediterranean diet would cause changes in an individual's ...
BOSTON — Use and abuse of "bath salts," a new group of designer drugs, have been increasing in recent years, particularly among teenagers. Poison control centers received over 2,000 calls last year for patients with delusions, hallucinations and paranoia following "bath salt" use. Although the synthetic compounds found in "bath salts" are routinely changing in order to circumvent laws on banned substances, federal legislation recently added MDPV, a common constituent in "bath salts," to the list of Schedule 1 drugs – a list that includes cocaine, methamphetamine, ecstasy ...
Washington, DC (April 18, 2013) – From the T-101 to Data from Star Trek, humans have been presented with the fictional dilemma of how we empathize with robots. Robots now infiltrate our lives, toys like Furbies or robot vacuum cleaners bring us closer, but how do we really feel about these non-sentient objects on a human level? A recent study by researchers at the University of Duisburg Essen in Germany found that humans have similar brain function when shown images of affection and violence being inflicted on robots and humans.
Astrid Rosenthal-von der Pütten, Nicole ...
Scientists from King's College London have identified patterns of epigenetic changes involved in autism spectrum disorder (ASD) by studying genetically identical twins who differ in autism traits. The study, published in Molecular Psychiatry, is the largest of its kind and may shed light on the biological mechanism by which environmental influences regulate the activity of certain genes and in turn contribute to the development of ASD and related behaviour traits.
ASD affects approximately 1 in 100 people in the UK and involves a spectrum of disorders which manifest themselves ...
Ancient DNA recovered from a series of skeletons in central Germany up to 7500 years old has been used to reconstruct the first detailed genetic history of modern Europe.
The study, published today in Nature Communications, reveals a dramatic series of events including major migrations from both Western Europe and Eurasia, and signs of an unexplained genetic turnover about 4000-5000 years ago.
The research was performed at the University of Adelaide's Australian Centre for Ancient DNA (ACAD). Researchers used DNA extracted from bone and teeth samples from prehistoric ...
Animal sanctuaries can play an important role in rehabilitating goats and other animals that have suffered from neglect, according to scientists at Queen Mary, University of London.
In this first scientific study of rescued animals, the researchers examined moods in 18 goats, nine of which had endured poor welfare, such as inappropriate diet, and lack of space or shelter before arriving at a sanctuary. They created a spatial awareness test, which involved giving the animals an opportunity to look for food, to understand the link between poor welfare and the goats' mental ...
COLUMBUS, Ohio – Taking a specific form of a vitamin E supplement can accelerate the health benefits that occur when people quit smoking, new research suggests.
In the small study, improvement in blood vessel function associated with the added vitamin E potentially translates into an estimated 19 percent greater drop in future risk for cardiovascular disease.
Smokers were recruited to participate in a study to quit smoking for seven days, with blood markers of inflammation and blood vessel function measured before and after the trial. After seven days of not smoking, ...
(Santa Barbara, Calif. –) Researchers at University of California, Santa Barbara, in collaboration with colleagues at the École Polytechnique in France, have conclusively identified Auger recombination as the mechanism that causes light emitting diodes (LEDs) to be less efficient at high drive currents.
Until now, scientists had only theorized the cause behind the phenomenon known as LED "droop"—a mysterious drop in the light produced when a higher current is applied. The cost per lumen of LEDs has held the technology back as a viable replacement for incandescent bulbs ...
